SCHEMBL6232209

SCHEMBL6232209

C=C[CH]N=NN

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10817609 0.76
SCHEMBL15132787 0.72
SCHEMBL19905517 0.67
SCHEMBL4796295 0.64
SCHEMBL18714887 0.57
SCHEMBL11820116 0.56
Butadiene SCHEMBL28082005 0.55
SCHEMBL15196004 0.54
SCHEMBL4069944 0.54
SCHEMBL19331986 0.54

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0865283-A4 2-DEOXYSTREPTAMINE AS A MOLECULAR SCAFFOLD FOR PREPARING FUNCTIONALLY AND SPACIALLY DIVERSE MOLECULES AND PHARMACEUTICAL COMPOSITIONS THEREOF ANADYS PHARMACEUTICALS INC (US) 2005-07-20 EP claimed
US-6140361-A FOR INHIBITING BINDING OF HUMAN IMMUNODEFICIENCY VIRUS REV PROTEIN TO REV RESPONSIVE ELEMENTS (RRE) SCRIPTGEN PHARMACEUTICALS, INC. (US) 2000-10-31 US claimed
EP-0865283-A1 2-DEOXYSTREPTAMINE AS A MOLECULAR SCAFFOLD FOR PREPARING FUNCTIONALLY AND SPACIALLY DIVERSE MOLECULES AND PHARMACEUTICAL COMPOSITIONS THEREOF Scriptgen Pharmaceuticals Inc. (US) 1998-09-23 EP claimed
WO-1997009053-A9 2-DEOXYSTREPTAMINE AS A MOLECULAR SCAFFOLD FOR PREPARING FUNCTIONALLY AND SPATIALLY DIVERSE MOLECULES AND PHARMACEUTICAL COMPOSITIONS THEREOF 1997-05-01 WO claimed
WO-1997009053-A1 2-DEOXYSTREPTAMINE AS A MOLECULAR SCAFFOLD FOR PREPARING FUNCTIONALLY AND SPATIALLY DIVERSE MOLECULES AND PHARMACEUTICAL COMPOSITIONS THEREOF SCRIPTGEN PHARMACEUTICALS, INC. (US) 1997-03-13 WO claimed